Related Experiment Video
Updated: May 6, 2026
06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.6K
Thiopurine toxicity.
Kl de Wit1, Be White, D Goldsmith
1Academic FY2 in the Department of Medicine, Guys and St Thomas NHS Foundation Trust, London.
British Journal of Hospital Medicine (London, England : 2005)
|October 23, 2013
Summary
Thiopurines, developed in 1953, are crucial immunosuppressant and antineoplastic drugs. They are vital for treating leukemia and preventing organ transplant rejection.
Area of Science:
- Pharmacology and Medicine
- Immunology
- Oncology
Background:
- Thiopurines represent a significant class of drugs with dual immunosuppressant and antineoplastic properties.
- Their development by Gertrude Elion and George Hitchings marked a milestone in medical treatment.
Purpose of the Study:
- To highlight the historical development and key applications of thiopurine drugs.
- To underscore their role in managing leukemia and preventing transplant rejection.
Main Methods:
- Historical review of drug development and patent information.
- Analysis of clinical applications based on existing literature.
Main Results:
- Thiopurines were patented in 1953.
- Initial use targeted leukemia treatment.
- Subsequent application extended to preventing transplant rejection.
Conclusions:
- Thiopurines have a well-established history in medicine.
- Their efficacy in treating leukemia and preventing transplant rejection is clinically significant.
Related Concept Videos
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
101
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
101
01:24Drug Toxicity: Dose-Dependent Reactions
245
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245
01:16Drug toxicity: Idiosyncratic Reactions
232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
01:24Drug Toxicity: Risk factors
250
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
250
01:00Drug Toxicity: Overview
313
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
313